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Abstract
Background: An increasing number of reports are calling our attention to the worldwide spread of leishmaniasis.
The urbanization of zoonotic visceral leishmaniasis (VL) has been observed in different South American countries,
due to changes in demographic and ecological factors. In May 2006, VL was detected for the first time in the city
of Posadas (Misiones, Argentina). This event encouraged us to conduct a clinical and parasitological pilot survey on
domestic dogs from Posadas to identify their potential role as reservoirs for the disease.
Methods: One hundred and ten dogs from the city of Posadas were included in the study. They were selected
based on convenience and availability. All dogs underwent clinical examination. Symptomatology related to canine
leishmaniasis was recorded, and peripheral blood and lymph node aspirates were collected. Anti-Leishmania
antibodies were detected using rK39-immunocromatographic tests and IFAT. Parasite detection was based on
peripheral blood and lymph node aspirate PCR targeting the SSUrRNA gene. Molecular typing was addressed by
DNA sequence analysis of the PCR products obtained by SSUrRNA and ITS-1 PCR.
Results: According to clinical examination, 69.1% (76/110) of the dogs presented symptoms compatible with
canine leishmaniasis. Serological analyses were positive for 43.6% (48/110) of the dogs and parasite DNA was
detected in 47.3% (52/110). A total of 63 dogs (57.3%) were positive by serology and/or PCR. Molecular typing
identified Leishmania infantum (syn. Leishmania chagasi) as the causative agent.
Conclusions: This work confirms recent findings which revealed the presence of Lutzomyia longipalpis, the vector
of L. infantum in this area of South America. This new VL focus could be well established, and further work is
needed to ascertain its magnitude and to prevent further human VL cases.
Background
In South America Leishmania infantum (syn. Leishma-
nia chagasi) is the causative agent of visceral leishma-
niasis (VL), a systemic infection which is fatal if not
treated. The primary vectors are Lutzomyia longipalpis
female sand flies, and infected domestic dogs are the
main reservoirs [1]. However, Dantas-Torres recently
highlighted the need to use proper diagnostic tools to
identify the species of Leishmania involved in each
case of canine leishmaniasis irrespective of the clinical
form [2]; this is an important issue to take into account
when a new focus is being described.
The worldwide incidence of VL is estimated to be
500000 cases/year, with more than 50000 related deaths.
In several areas of the world, there is a clear and dis-
turbing increase in the number of VL cases. For exam-
ple, in Northeastern Brazil the incidence raised from
1840 cases in year 1998 to 6000 in 2002 [3].
At present, a growing number of reports are calling
our attention to a worldwide spread of leishmaniasis,
including the urbanization of VL in different South
American countries due to changes in demographic and
ecological factors [4-8].
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Salomón, et al. [9] on the first urban VL focus in
Posadas (Misiones, Argentina), which appeared in 2006
involving humans and dogs. That work indicated both:
i )t h ep r e s e n c eo fLu. longipalpis in Misiones, where it
was reported previously to be anecdotal [10] and ii) the
presence of Leishmania sp. infection in 13 out of 27
dogs studied [9]. At present, 58 human VL cases have
been reported in Posadas (2 in year 2006, 14 in 2007, 17
in 2008, 24 in 2009 and one up to April 30
th 2010),
with 6 related deaths [[11], Misiones Ministry of Health
personal communication].
Encouraged by the emergence of the first human VL
cases, we conducted a canine serological and parasitolo-
gical pilot survey to: i) identify Leishmania infection in
dogs, and thus their possible role as reservoirs, and ii)
identify de Leishmania species circulating in this emer-
ging VL focus.
Methods
Study location
The serological and parasitological pilot survey was con-
d u c t e df r o m1J u l yt o1 5A u g u s t2 0 0 6i nt h ec i t yo f
Posadas (27°23’S, 55°54’W), located in the southwest of
Misiones province, Northeast Argentina.
Misiones is bordered by Brazil to the north and by
Paraguay to the east. The city of Posadas has a global
surface of 324 Km
2, and is characterized by a subtropi-
cal humid climate; annual rain is 1700 mm and average
temperature 21.5°C. Posadas, which accounts for 29% of
the total population of the province, had an estimated
population of 297499 inhabitants in 2008; 98.8% from
urban areas and 32.6% below the poverty line [12].
Study animals and samples
Our study was based on a convenience sample of 110
dogs originating from two sources: i) 83 dogs from two
different canine shelters, located in the outskirts of
Posadas, which admit dogs from the city: 59 from the
non-profit civil association ‘El Refugio’ (Itaembé Miní
area) and 24 from the Municipal Animal Health Insti-
tute-IMUSA (El Zaimán area), and ii) 27 dogs with own-
ers that attended a local veterinary clinic for routinely
care.
All dogs underwent clinical examination by a local
veterinarian, searching for symptoms related to canine
leishmaniasis (CanL). The presence of one or more of
the following was considered for the clinical diagnosis of
CanL: lymphadenopathy, onychogryphosis, skin lesions,
weight loss, conjunctivitis and alopecia.
After examination one ml peripheral blood (PB) was
obtained from 110 dogs and collected in EDTA-containing
tubes; lymph node aspirates (LN) were obtained from 94
dogs and further diluted in 500 μl ethanol 70%. Once
obtained, samples were stored at 4°C until shipment to the
WHO Collaborating Centre for Leishmaniasis (Madrid,
Spain) for serological and molecular diagnosis.
Informed consent was obtained from each dog owner
and from the canine shelter responsible before clinical
examination and sampling of the dogs. Research proce-
dures were approved by the corresponding research
review boards of Universidad Miguel Hernández and
Misiones Ministry of Public Health.
Serological diagnosis
Anti-Leishmania antibodies detection was performed by
two different approaches: a) rK39-immunochromato-
graphic test (rK39-ICT; Kalazar Detect™ Rapid test,
InBIOS International, Seattle, WA), using 25 μlo fp e r -
ipheral blood and following the manufacturer’si n s t r u c -
tions; and b) Immunofluorescence antibody test (IFAT)
following a standard method, using 10 μlo f2×1 0
7 L.
infantum promastigotes/ml in 1× PBS per well as anti-
gen (reference strain MHOM/FR/78/LEM-75) and 1 μl
plasma for the analysis. The IFAT threshold titre for
positivity was 1/160 [13]. Considering the present work
a pilot study, replicate testing of the samples was not
performed.
Molecular diagnosis
Parasite detection was done by means of nested-PCR
targeting the Leishmania SSUrRNA gene (LnPCR) as
described elsewhere, this protocol is Leishmania genus
specific and uses the primer pair R221 (5’-GGT TCC
T T TC C TG A TT T AC G - 3 ’)a n dR 3 3 2( 5 ’-GGC CGG
TAA AGG CCG AAT AG-3’) in the first reaction, and
the primer pair R223 (5’-TCC CAT CGC AAC CTC
GGT T-3’)a n dR 3 3 3( 5 ’-AAA GCG GGC GCG GTG
CTG-3’) in the nested reaction [14]. Starting material
for DNA extraction was: i) 100 μL PB and ii) the pellet
obtained after centrifugation (6000 rpm in a benchtop
microcentrifuge for 10 min) and PBS 1× washing of the
LN dilution obtained from each dog. DNA was
extracted by conventional phenol-chloroform extraction
and ethanol precipitation and further eluted in 100 μl
sterile distilled water.
Molecular typing of the parasites
Leishmania molecular typing was carried out by
sequence analysis of both the LnPCR products obtained
from PB and LN samples, and the ITS-1 PCR products
obtained from PB samples of LnPCR positive dogs. ITS-
1 PCR was performed as described elsewhere with the
primer pair LITSR (5’-CTG GAT CAT TTT CCG
ATG-3’) and L5.8S (5’-TGA TAC CAC TTA TCG CAC
TT-3’) and used only for typing purpose [15]. Direct
sequencing of the PCR products was performed with
forward and reverse primers; using the Big-Dye
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and the automated ABI PRISM 377 DNA sequencer
(Applied Biosystems, Foster City, CA). Sequences
obtained were analyzed and edited using Lasergene®
sequence analysis software (DNASTAR, Madison, WI).
Statistical analyses
Data recorded during the clinical examination and
results from serological analyses were introduced in an
Excel® data sheet (Microsoft Office 2003). The associa-
tion between the different variables was analyzed with
the SPSS statistical software version 16.0, using the chi-
square test with Yate’s correction. A p-value of <0.05
was considered as statistically significant.
Results
Clinical examination
Dogs were grouped according to their age in four differ-
ent groups. Group 1 (≤1 year) consisted in 23/110 dogs
(20.9%), group 2 (2-5 years) in 55/110 (50.0%), group 3
(6-10 years) in 18/110 (16.4%), and group 4 (>10 years)
in 14/110 (12.7%). Male/female ratio for all groups
together was 1.5/1 (66 male/44 female). Eighty-three out
of the 110 dogs (75.4%) were mongrel and 27/110
(24.6%) were from different breeds.
After clinical examination, 34 out of 110 dogs (30.9%)
were classified as asymptomatic, while 76/110 (69.1%)
presented one or more clinical signs related to canine
leishmaniasis. The frequency of the different symptoms
in the 76 symptomatic dogs is presented in table 1.
Nineteen out of the 76 symptomatic (25%) dogs were
classified as oligosymptomatic (1 or 2 symptoms), while
57 (75%) were classified as polysymptomatic (more than
3 symptoms).
Serological and molecular diagnosis
A l ld o g sw e r ea n a l y z e db yr K 3 9 - I C Ta n d / o rI F A T .
rK39-ICT was positive in 42/109 (38.5%) of the dogs,
and IFAT in 40/102 (39.2%). The combination of both
serological methods indicated that 48/110 (43.6%) of
them were seropositive. For 101 dogs tested by both ser-
ological methods, the concordance between rK39-ICT
and IFAT results was 90.1%. Dogs were considered as
seropositive when rK39-ICT and/or IFAT yielded a
positive result.
A l ld o g sw e r ea n a l y s e db yP B - L n P C Ra n d / o rL N -
LnPCR. Leishmania DNA was detected in PB of 23/109
(21.1%) and in LN of 47/94 (50.0%) of the dogs studied.
The combination of both PCR approaches detected the
parasite DNA in 52/110 (47.3%) dogs. For 93 dogs on
which PCR was performed on both biological samples
the concordance of PCR results was 63.4%. Dogs were
considered as parasite positive when leishmanial DNA
was detected by PB-LnPCR and/or LN-LnPCR.
Dogs were considered as infected when they were ser-
opositive and/or parasite positive. Table 2 provides a
detailed description of serology and PCR results with
regards to the origin, sex, breed, age group and clinical
status of 110 dogs on which both serology and PCR
data were available.
Figure 1 shows a flowchart including data on clinical
examination, the number of samples processed by each
diagnostic test and those testing positive. The number
of dogs positive with one, two, three or four diagnostic
approaches according to their clinical status is shown in
Table 3.
Table 1 Frequency of signs/symptoms related to canine
leishmaniasis in 76 symptomatic dogs
Symptoms Frequency (%)
Skin lesions 73/76 (96.0%)
Lymphadenopathy 68/76 (89.5%)
Onychogryphosis 47/76 (61.8%)
Weight loss 38/76 (50.0%)
Conjunctivitis 32/76 (42.1%)
Table 2 Detailed description of serology and PCR results
with regards to different parameters in 110 dogs
Sero-
pos*
Parasite-pos** Infected***
Origin Owner
(N = 27)
14 (51.8%) 14 (51.8%) 18 (66.7%)
Canine shelter
(N = 83)
34 (40.9%) 38 (45.8%) 45 (54.2%)
Sex Male
(N = 66)
30 (45.4%) 32 (48.5%) 40 (60.6%)
Female
(N = 44)
18 (40.9%) 20 (45.4%) 23 (52.3%)
Breed Defined breed
(N = 27)
16 (59.2%) 11 (40.7%) 16 (59.2%)
Mongrel
(N = 83)
32 (38.5%) 41 (49.4%) 47 (56.6%)
Age
Group
Group 1
(N = 23)
12 (52.2%) 12 (52.2%) 15 (65.2%)
Group 2
(N = 55)
24 (43.6%) 29 (52.7%) 34 (61.8%)
Group 3
(N = 18)
5 (27.8%) 7 (38.9%) 7 (38.9%)
Group 4
(N = 14)
7 (50.0%) 4 (28.6%) 7 (50.0%)
Clinical
status
Symptomatic
(N = 76)
39 (51.3%) 42 (55.3%) 50 (65.8%)
Asymptomatic
(N = 34)
9 (26.5%) 10 (29.4%) 13 (38.2%)
Total (N = 110) 48 (43.6%) 52 (47.3%) 63 (57.3%)
*Sero-pos: seropositive by rK39-ICT and/or IFAT. **Parasite-pos: LnPCR positive
on PB and/or LN samples. ***Infected: Sero-pos and/or Parasite-pos.
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DNA sequences from LnPCR products were obtained for
23 PB and 45 LN samples from 53 different dogs. And
DNA sequences from ITS-1 PCR products were obtained
for PB samples from 17 different dogs. Once edited the
sequences obtained were used for BLAST search against
GenBank™ database [16]. The sequences obtained from the
LnPCR products returned 100% identity with SSUrRNA
gene sequences of Leishmania donovani complex species
(L. infantum, L. donovani), while the sequences obtained
from the ITS-1 PCR products returned 100% identity with
ITS-1 sequences of L. infantum.
Statistical analyses
No statistical association was observed between infec-
tion and age group (p = 0.279), sex (p = 0.387) or origin
(p = 0.256). However there was a significant association
between symptomatology and infection (p = 0.007).
Furthermore, a significant association between number
of symptoms and infection (p = 0.019) was observed.
Particularly, the presence of the following symptoms
presented significant association with infection: lympha-
denopathy, onychogryphosys and conjunctivitis
(p < 0.05); while skin lesions and weight loss were not
associated (p > 0.05).
Discussion
Leishmania infection was confirmed either by molecular
and/or serological methods in 63/110 (57.3%) dogs. Cur-
rent entomological data reporting the presence of Lu.
longipalpis in Posadas [9], together with the presence of
L. infantum infection in urban dogs indicates that the
transmission cycle of zoonotic VL (ZVL) could be well
established, and that further cases of human VL are
likely to appear. It has been shown in Brazil that human
epidemics of VL are usually preceded, or concomitant
to high infection rates in the canine population [17-19].
The emergence of 58 human VL cases in Posadas since
2006 supports this possibility. The limitations of this
pilot study, based on a convenience sampling, do not
allow drawing solid conclusions. In addition most of the
dogs (83/110) were from a canine shelter, thus the data
do not have the power of a population-based random
sampling study to provide a view of the real prevalence
of Leishmania infection in the canine population. How-
ever the data present a consistent picture of this emer-
ging focus of ZVL.
Infected symptomatic dogs are considered to be the
main reservoirs of ZVL leishmaniasis, in the present
study these represent 45.4% (50/110) of the dogs stu-
died. However, infected asymptomatic dogs are also said
to play a role in transmission [20-22], in this study these
represent 11.8% (13/110) of the total. In spite of the sta-
tistical association between infection and symptomatol-
ogy, the present study also highlights the low specificity
of the clinical diagnosis of CanL; in fact 34.2% (26/76)
of the symptomatic dogs (one or more of the before
mentioned symptoms) presented negative results for
both serology and PCR. Thus, as suggested by recent
reviews, reliable laboratory-based diagnostic tests should
Figure 1 Flowchart including data on clinical examination, the
number of samples processed by each diagnostic test and
those testing positive. Flowchart including data on clinical
examination, and number of samples processed. Sero (+):
seropositive by rK39-ICT and/or IFAT. Para (+):LnPCR positive on PB
and/or LN samples. Infected: Sero (+) and/or Para (+).
Table 3 Number of dogs analyzed by all 4 diagnostic methods testing positive with one, two, three or four diagnostic
approaches (rK39-ICT, IFAT, PB-LnPCR and LN-LnPCR) according to their clinical status
Number of positive tests Total N = 85 (%) Asymptomatic N = 20 (%) Symptomatic N = 65 (%)
0 32/85 (37.6) 11/20 (55.0) 21/65 (32.3)
1 14/85 (16.4) 3/20 (15.0) 11/65 (16.9)
2 10/85 (11.7) 1/20 (5.0) 9/65 (13.8)
3 15/85 (17.6) 2/20 (10.0) 13/65 (20.0)
4 14/85 (16.4) 3/20 (15.0) 11/65 (16.9)
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logical studies [23,24].
In areas where ZVL is endemic the prevalence of
infected dogs tends to be high, with a greater proportion
of asymptomatic ones [25]. In the present study, and
unlike what happens in traditional endemic areas for
ZVL, most of the infected dogs were symptomatic. This
could be due to a recent introduction of L. infantum in
the area where, as a naïve population, most of the dogs
infected would develop the disease. It is also reported in
ZVL endemic areas an increasing prevalence of seropo-
sitive dogs with age, and a final decrease in those aged
≥7 years [26-28]. In dogs from the present study we
observed no increase in seropositivity nor in parasite
DNA detection related with the age of the dogs (p >
0.05). This finding could also be consistent with the
hypothesis of a recent introduction of L. infantum.T h e
results of the diagnostic tests employed also support the
above mentioned. In the recent review by Baneth, et al.
[29] it is stated that in endemic foci the number of PCR
positive dogs will exceed the number of seropositive;
however in the present study there were no great differ-
ences between the rates of infection detected by serol-
ogy and PCR.
Concerning the serological test employed in this
s t u d y( r K 3 9 - I C Ta n dI F A T )t h e yh a v ep r e s e n t e dac o n -
cordance of 90.1%. IFAT has long been considered as
the gold standard in canine leishmaniasis serodiagnosis
[1,30], and different rK39 rapid tests have also shown a
good performance in field studies [31]. According to
different authors their sensitivity ranges from 85.5 to
90% for IFAT and 72 to 96.7% for rK39-ICT, while
their specificity ranges from 94.7 to 100% for IFAT
and 61.75-100% for rK39-ICT [24,31-33]. However,
Mettler et al [33] reported a lower sensitivity for these
methods in asymptomatic infected dogs, 29.4% for
IFAT and 52.9% for rK39-ICT. In our study no big dif-
ferences were observed in the performance of these
tests between asymptomatic and symptomatic dogs; In
PCR-positive asymptomatic dogs rK39-ICT and IFAT
were positive for 55.5% and 60% of the dogs respec-
tively, while in PCR-positive symptomatic dogs both
methods were positive for 66.6% of the dogs. Cross
reactions with other infectious agents such as Babesia
canis, Ehrlichia canis, Neospora caninum, Hepatozoon
canis and Trypanosoma cruzi have also been described
[31,33,34]. Some false-positive results of rK39-ICT
have been also attributed to unknown blood factors
present in dog blood [32]. Although we cannot cate-
gorically rule out cross-reactions with T. cruzi or
L. braziliensis in our study, this is very unlikely as the
presence of autochthonous infections by these parasites
h a sn o tb e e nr e p o r t e di nt h ec i t yo fP o s a d a s ,w h e r e
this study took place.
With regards to the molecular typing of the parasites
this is, to our knowledge and taking into account the
review by Salomón et al. [9], the first report on molecu-
lar identification of autochthonous L. infantum infection
in Argentina.
The recently established focus of human and canine
VL in Asunción, Paraguay [35,36], could have been,
because of its proximity, the source of the introduction
of VL in Northern Argentina [37]. To ascertain the ori-
gin of the parasites in this new VL focus a wide popula-
tion genetics based study involving L. infantum strains
from different South American endemic areas could be
very helpful. For this purpose multi locus microsatellite
typing seems to be the most appropriate tool [38]. And
to ascertain since when it is established, powerful epide-
miological studies in human and canine population
must be done. These studies should address: i) retro-
spective analyses of human and canine samples from
patients/dogs attending the different health/veterinary
centres in the area with symptoms compatible with
human VL/CanL; ii) leishmanin skin test (in humans)
and serological surveys (in both humans and dogs) to
estimate the prevalence of parasite contact in different
age groups.
Conclusions
This pilot study confirms the presence of CanL due to
L. infantum in Posadas (Misiones, Argentina), an area
where the disease has been recently reported. Though
the present work has the limitations of not being a
population-based random sampling study, and does not
provide an accurate view of the real prevalence of Leish-
mania infection in the canine population of Posadas, it
indicates that this new VL focus could be well estab-
lished, and further work is needed to ascertain its mag-
nitude and to prevent further human VL cases.
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